0.6302

5.94% -0.0398

Pre-market: .63 -0.0002 -0.03%

Talphera Inc (TLPH)

Overview News Price History Discussions Forecast

Talphera Inc stock is traded at $0.6302, with a volume of 55,298. It is down -5.94% in the last 24 hours and down -0.80% over the past month. Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.

Previous Close:

$0.67

Open:

$0.647

24h Volume:

55,298

Relative Volume:

0.49

Market Cap:

$10.73M

Revenue:

$2.82M

Net Income/Loss:

$-14.20M

P/E Ratio:

-0.7414

EPS:

-0.85

Net Cash Flow:

$-15.13M

1W Performance:

+8.66%

1M Performance:

-0.80%

6M Performance:

-27.56%

1Y Performance:

-28.39%

1-Day Range:

$0.63

$0.6945

1-Week Range:

$0.5511

$0.6945

52-Week Range:

$0.501

$1.61

Talphera Inc Stock (TLPH) Company Profile

Name

Talphera Inc

Sector

Healthcare (1176)

Industry

Drug Manufacturers - Specialty & Generic (1)

Phone

650-216-3500

Address

1850 GATEWAY DRIVE, SAN MATEO

Employee

Twitter

Next Earnings Date

2024-11-06

Latest SEC Filings

TLPH's Discussions on Twitter

Compare TLPH with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TLPH Talphera Inc	0.6302	10.73M	2.82M	-14.20M	-15.13M	-0.85
ZTS Zoetis Inc	167.53	75.58B	9.15B	2.43B	2.31B	5.32
HLN Haleon Plc Adr	9.24	41.78B	14.26B	1.55B	0	0.3383
TAK Takeda Pharmaceutical Co Adr	13.10	41.53B	30.27B	1.93B	3.45B	0.6044
TEVA Teva Pharmaceutical Industries Ltd Adr	21.82	24.72B	16.77B	-959.00M	1.37B	-0.85
NBIX Neurocrine Biosciences Inc	145.88	14.77B	2.24B	385.90M	440.10M	3.73

Talphera Inc Stock (TLPH) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-20-20	Downgrade	Credit Suisse	Neutral → Underperform
Nov-11-19	Downgrade	Credit Suisse	Outperform → Neutral
Aug-05-19	Resumed	Credit Suisse	Outperform
Jul-10-19	Resumed	Credit Suisse	Outperform
Apr-24-19	Resumed	B. Riley FBR	Buy
Feb-15-19	Initiated	Credit Suisse	Outperform
Oct-23-18	Initiated	B. Riley FBR	Buy
Oct-13-17	Downgrade	Jefferies	Buy → Hold
Oct-13-17	Reiterated	RBC Capital Mkts	Outperform
Jul-14-17	Resumed	Jefferies	Buy
Sep-15-16	Reiterated	ROTH Capital	Buy
Aug-05-16	Downgrade	Stifel	Buy → Hold
Oct-30-15	Upgrade	Jefferies	Hold → Buy
Oct-05-15	Reiterated	ROTH Capital	Buy
Sep-02-15	Initiated	H.C. Wainwright	Buy
Jul-10-15	Resumed	ROTH Capital	Buy
May-06-15	Reiterated	Mizuho	Neutral
May-05-15	Reiterated	RBC Capital Mkts	Outperform
Mar-10-15	Reiterated	RBC Capital Mkts	Outperform
Mar-09-15	Downgrade	Mizuho	Buy → Neutral

View All

Talphera Inc Stock (TLPH) Latest News

Jan 14, 2025

FDA to review Talphera's request to amend NEPHRO study By Investing.com - Investing.com Canada

Jan 14, 2025

FDA to review Talphera’s request to amend NEPHRO study By Investing.com - Investing.com Nigeria

Jan 14, 2025

FDA to review Talphera's request to amend NEPHRO study - Investing.com

Jan 14, 2025

Talphera Announces Agreement with the FDA for Prior Approval Supplement Review to Reduce the Number of Patients in the NEPHRO CRRT Study - Marketscreener.com

Jan 14, 2025

Dec 26, 2024

Talphera faces Nasdaq delisting over share price rule By Investing.com - Investing.com UK

Dec 11, 2024

Acelrx Announces Dsuvia® Milestone C Approval; Provides Revenue Guidance for the First Quarter 2020 - Marketscreener.com

Dec 11, 2024

Dec 07, 2024

Talphera to Host Third Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, November 13, 2024 - Kilgore News Herald

Dec 07, 2024

Dec 06, 2024

Talphera CEO Vincent J. Angotti acquires $3,199 in common stock - Investing.com

Dec 06, 2024

Talphera CEO Vincent J. Angotti acquires $3,199 in common stock By Investing.com - Investing.com UK

Dec 06, 2024

Dec 02, 2024

Talphera CEO Vincent J. Angotti buys $3,649 in company stock By Investing.com - Investing.com Canada

Dec 02, 2024

Talphera CFO Raffi Asadorian sells shares worth $118 - Investing.com India

Dec 02, 2024

Talphera CEO Vincent J. Angotti buys $3,649 in company stock - Investing.com India

Dec 02, 2024

Talphera CFO Raffi Asadorian sells shares worth $118 By Investing.com - Investing.com Canada

Dec 02, 2024

Nov 16, 2024

Talphera Third Quarter 2024 Earnings: US$0.13 loss per share (vs US$0.085 loss in 3Q 2023) - Yahoo Finance

Nov 16, 2024

Nov 15, 2024

Talphera (FRA:R5XA) Inventories, Raw Materials & Components : €0.00 Mil (As of Jun. 2024) - GuruFocus.com

Nov 15, 2024

Nov 14, 2024